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Abstract
Acetylcholinesterase (AChE) inhibitors are widely used as pesticides and drugs. Their primary effect is the overstimulation of
cholinergic receptors which results in an improper muscular function. During vertebrate embryonic development nerve
activity and intracellular downstream events are critical for the regulation of muscle fiber formation. Whether AChE
inhibitors and related neurotoxic compounds also provoke specific changes in gene transcription patterns during vertebrate
development that allow them to establish a mechanistic link useful for identification of developmental toxicity pathways
has, however, yet not been investigated. Therefore we examined the transcriptomic response of a known AChE inhibitor,
the organophosphate azinphos-methyl (APM), in zebrafish embryos and compared the response with two non-AChE
inhibiting unspecific control compounds, 1,4-dimethoxybenzene (DMB) and 2,4-dinitrophenol (DNP). A highly specific
cluster of APM induced gene transcripts was identified and a subset of strongly regulated genes was analyzed in more
detail. The small heat shock protein hspb11 was found to be the most sensitive induced gene in response to AChE inhibitors.
Comparison of expression in wildtype, ache and sop
fixe mutant embryos revealed that hspb11 expression was dependent on
the nicotinic acetylcholine receptor (nAChR) activity. Furthermore, modulators of intracellular calcium levels within the
whole embryo led to a transcriptional up-regulation of hspb11 which suggests that elevated intracellular calcium levels may
regulate the expression of this gene. During early zebrafish development, hspb11 was specifically expressed in muscle
pioneer cells and Hspb11 morpholino-knockdown resulted in effects on slow muscle myosin organization. Our findings
imply that a comparative toxicogenomic approach and functional analysis can lead to the identification of molecular
mechanisms and specific marker genes for potential neurotoxic compounds.
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Introduction
Understanding of chemical-induced biological responses and
their underlying pathways is indispensable to evaluate the impact
of chemicals on organisms. Toxicogenomic analysis is an effective
approach to better understand these pathways and their related
adverse effects [1–3]. A major step forward is the identification of
chemical-specific gene expression signatures which could be used
to assign mechanisms of action (MoA) to non-characterized or
unknown compounds [4]. Changes in gene expression by exposure
to chemicals can be directly inferred from binding of a compound
to a transcription factor. Prominent examples are the aryl
hydrocarbon or estrogen receptors. However, many compounds,
e.g. neurotoxic chemicals, may not interfere directly with a
transcription factor but affect gene expression patterns indirectly
through a complex signaling cascade.
In the present study, we examined the toxicogenomic response
to azinphos-methyl (APM), an AChE-inhibitor, using zebrafish
embryos as a model. AChE catalyzes the hydrolysis of the
neurotransmitter acetylcholine (ACh) and is important for the
cholinergic neurotransmission. Furthermore, non-cholinergic
functions of AChE have been described in neuronal development
[5,6]. AChE is the target of many toxins like insecticides, chemical
weapons, and snake venoms [7]. Prolonged AChE inhibition or
complete lack of AChE results in an accumulation of ACh and
overstimulation of the muscle, leading to spasms and myopathy-
like phenotypes [5,8,9]. The zebrafish embryo has been selected as
model for the following reasons: (i) Toxicogenomic approaches in
the zebrafish embryo have recently shown that chemicals can
provoke specific and sensitive gene expression changes [10–12]. (ii)
It has been described that AChE is required for neuronal and
muscular development in zebrafish embryos and no other ACh-
hydrolyzing enzymes are present in this organism [5,13,14]. (iii)
Appropriate mutant strains that either lack AChE (ache) or nAChR
(sop
fixe) activity are available to support functional analyses.
First, we compared changes in gene expression patterns
provoked by APM with those of two non-AChE inhibiting
compounds, 1,4-dimethoxybenzene (DMB), a narcotic (baseline
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decoupling agent. The test compounds were selected to allow
the identification of genes specifically responding to compounds
inhibiting acetylcholine esterase. Neurotoxicity is a common MoA
among compounds exhibiting an excess toxicity (i.e. ratio of
predicted baseline toxicity versus measured toxicity). The
organophosphate insecticide and known acetylcholine esterase
inhibitor APM [15] exhibits a high acute excess toxicity, i.e. the
measured LC50 is 1340fold below the predicted acute toxicity [16].
This clearly supports the specific neurotoxic mode of action. The
other compounds were selected as two different non-neurotoxic
reference compounds in order to allow the identification of MoA
specific gene expression patterns. DNP, an industrial chemical, is a
protonionophor or uncoupling agent that disrupts generation of
ATP from proton-gradients in the mitochondria [17]. DNP has a
moderate excess toxicity of 23. In contrast to APM and DNP the
acute fish toxicity of DMB is in the same order of magnitude as the
predicted baseline-toxicity. Subsequently, detailed transcriptional
analyses of selected genes were applied to link gene expression
changes to the MoA. We investigate the expression of the small
heat shock protein hspb11 in wildtype, ache and sop
fixe mutant
embryos in more detail and study its role during development. For
the first time, we demonstrate that developmental hspb11
expression is muscle-activity dependent and is indirectly regulated
by intracellular calcium levels. Furthermore, Hspb11 is required
for slow muscle myofibril organization in the embryo. These
results show that a comparative toxicogenomic approach and
functional analysis can lead to the identification of molecular
mechanisms and specific marker genes for potential neurotoxic
compounds.
Results
Toxicogenomic responses to APM exposure are highly
specific
For transcriptional profiling it was aimed that similar – with
respect to toxicity – effect concentrations were used that did not
induce severe morphological changes. Based on concentration
response curves of zebrafish embryos exposed from 2-50 hours
post fertilization (hpf) we selected the modeled LC10 (6 mM for
APM, 509 mM for DMB and 14 mM for DNP) as exposure
concentrations for the microarray study (Figure S1). Exposures to
this effect level did not induce gross morphological changes.
However, APM inhibited zebrafish AChE enzymatic activity half-
maximally at 0.15 mM and caused an almost complete block of
AChE activity at 6 mM (Figure S2). It is known that in ache mutants
the lack of AChE activity can cause a progressive myopathy in
zebrafish embryos [5,8]. To test whether APM caused similar
defects we performed a birefringence analysis of embryos exposed
from 12–72 hpf to 6 mM APM (according to [8]). APM treated
embryos were immobile and displayed a reduced birefringence
compared to controls (Figure 1). This suggests that a prolonged
exposure with 6 mM APM caused changes in muscular structures.
For the microarray analysis we exposed zebrafish embryos for
24 h (26–50 hpf) and 48 h (2–50 hpf). The different exposure
durations were chosen in order to identify potential differences
with respect to primary or secondary responses. By hierarchical
cluster analysis we identified an APM specific cluster of
significantly induced genes after the 24 h as well as the 48 h
exposure (Figure S3). The observed differences, however, were
more prominent after 24 h of exposure. In order to identify
pathways, associated with the transcriptional changes, a gene set
enrichment analysis (GSEA) was performed. Some of the identified
gene sets in the 24 h and 48 h treatments referred to factors/genes
involved in neuronal and muscle function/differentiation (axon
guidance, neurogenesis, voltage gated channel activity, muscle
structure and contraction, muscle tissue maintenance and
differentiation, supplement Table S1). More gene sets indicating
effects specific for neurons and muscles were identified for the 48 h
treatment. This may indicate that GSEA revealed (subtle) changes
in neuron or muscle structure and differentiation. However,
GSEA did not indicate interference with a specific signaling
pathway.
Transcriptional changes of the zebrafish embryo are
AChE-inhibitor concentration-dependent
In order to unravel the MoA leading to the expression changes
in the APM-specific gene cluster, we selected hspb11 (heat shock
protein, alpha-crystallin-related, b11), pdlim3b (PDZ and LIM
domain 3b), and socs3a (suppressor of cytokine signaling 3a) for
concentration-dependent quantitative expression analysis. The
selection of these genes was based on an initial RT-PCR
verification experiments (not shown) and the genes covered
different potential gene functions, e.g. stress response (hspb11),
immuno response (socs3a) and cytoskelatal assembly (pdlim3b). The
expression of these genes was gradually increased with elevated
APM concentrations. By means of qPCR an about two-fold
(pdlim3b), 8-fold (hspb11) and 6-fold (socs3a) maximum induction
after 24 h of exposure was observed (Figure 2A). Lowest observed
effect concentrations for gene expression changes compared to the
control were 0.7 mM and 3 mM of APM. Changes of hspb11 and
socs3a gene expression were already detected in 2 h (48 to 50 hpf)
APM exposures whereas the induction of hspb11 (approx. 20-fold)
exceeded the levels of expression after 24 h of exposure (Figure 2A
and B). The expression of hspb11 was also found to be induced by
other AChE inhibitors such as propoxur, disulfoton, and
galantamine (Figure S4). In contrast, the expression of socs3a was
not affected by the disulfoton treatment but also elevated after a
treatment with the non-AChE-inhibiting compound 4-nitrophenol
(Figure S4D). Pdlim3b was induced by all tested AChE inhibitors
and not by 4-nitrophenol. This suggests that hspb11 and pdlim3b
up-regulation is a specific response to AChE inhibitors. Due to the
strong and sensitive changes in hspb11 expression subsequent
functional analyses were focused on hspb11.
APM Mediated hspb11 Up-Regulation Depends on
nAChR Activity
APM-induced hspb11 expression could be mediated by the
overstimulation of the nAChR. In order to elucidate the role of
nAChR we analyzed hspb11 expression in the zebrafish ache and
sop
fixe mutant lines. Due to a point mutation in the ache gene,
homozygous ache mutant embryos completely lack AChE activity
Figure 1. Repression of AChE activity with APM resulted in a
reduced birefringence. (A) Wild-type zebrafish embryo axial
musculature is highly birefringent at 72 hpf. (B) APM [6 mM] exposure
from 12–72 hpf resulted in defects in the axial musculature, which are
shown by a reduced birefringence at 72 hpf.
doi:10.1371/journal.pone.0029063.g001
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fixe mutant harbors a point mutation in the d-subunit of
the muscular nAChR, encoded by the gene chrnd, and, hence, lacks
a functional nAChR. The d-subunit is expressed in all striated
muscles in embryonic and early larval stages [18]. Homozygous
(2/2) forms of both mutant embryos show severe impairment of
motility but are viable up to 5 days post fertilization (dpf).
Interestingly, the expression of hspb11 was strongly increased in
48 hpf ache 2/2 and repressed in sop
fixe 2/2 mutant embryos
(Figure 3A). Furthermore, exposure of sop
fixe 2/2 with APM (24–
48 hpf) did not result in further induction of hspb11 expression,
whereas sop
fixe siblings exposed to APM showed a 9-fold up-
regulation (Figure 3B). These data indicate that hspb11 induction
by APM is dependent on a functional nAChR.
Modulators of Cytosolic Calcium Levels Induce hspb11
Expression
ACh triggers muscular contraction by depolarizing muscle cells
and subsequent transient release of calcium from the sarcoplas-
matic reticulum. Calcium is not only the principal signaling
molecule for muscle contraction, it is also required for normal
development of muscles. It is hypothesized that excess activation of
AChR by unhydrolyzed ACh results in a large influx of calcium
ions in muscle cells. Indirect evidence for the role of calcium ions is
provided by studies that demonstrate a rescue of myopathy
(provoked by exposure to AChE inhibitors) by calcium channel
blockers [19–21]. Hence, we concluded that hspb11 induction by
AChE inhibition might be a result of increased cytosolic calcium
levels and increased muscular contractions mediated by overstim-
ulation of the nAChR. Hence, non-AChE inhibiting compounds
that lead to an increase in cytosolic calcium should increase hspb11
mRNA abundance. Therefore, we exposed zebrafish with
thapsigargin and caffeine. Thapsigargin is a specific blocker of
the sarco/endoplasmic reticulum calcium-ATPase (SERCA) [22].
Caffeine represents an activator of ryanodine receptors (RyRs), a
major mediator of calcium-induced calcium release in adaxial
muscles [23]. Exposure of wildtype embryos with either thapsi-
gargin [1 mM] for 2 h (48–50 hpf) or caffeine [2 mM] for 24 h
(26–50 hpf) resulted in an increased hspb11 gene expression.
Thapsigargin induced hspb11 mRNA expression 11-fold and
caffeine 23-fold (Figure 3C).
Hspb11 Is Expressed in Muscle Pioneers and Shows a
Muscle-activity Dependent Expression
In order to determine the function of hspb11, we first analyzed
the spatiotemporal hspb11 expression. At 18 hpf hspb11 is
expressed in the adaxial cells (i.e. somitic cells next to the
notochord, Figure 4A–A0). At 24 hpf hspb11 mRNA expression is
restricted to muscle pioneers (Figure 4B and B9). To elucidate
whether the hspb11 transcripts are exclusively expressed at these
early stages in muscle pioneers, we screened the hspb11 expression
pattern in smu 2/2 mutant embryos. smu mutants are defective in
smoothened - a mediator of hedgehog signals - and lack muscle
pioneers [24]. In smu 2/2 embryos hspb11 expression was lost
(Figure S5A and B) indicating that hspb11 is specifically expressed
in muscle pioneers. During later development hspb11 expression
was restricted to the notochord (Figure 4C). Interestingly, this
hspb11 expression pattern changed in APM exposed embryos and
in ache2/2 mutant embryos where transcripts were also detected
in the myotomes of the trunk in addition to the notochord
(Figure 4D and E). To test whether the developmental hspb11
expression is dependent on nAChR activity we investigated the
hspb11 expression pattern of sop
fixe mutants. Of a single cross of
heterozygote parents we used 30 embryos at 18 hpf for WISH. In
8 embryos, we did not detect any hspb11 expression pattern in
muscle pioneers whereas 22 embryos showed a wildtype hspb11
expression pattern, as expected for a recessive trait inherited in a
mendelian fashion (Figure 4F and H). Further, at 24 hpf the sop
fixe
2/2 embryos lack hspb11 expression pattern whereas sop
fixe+/?
embryos have a wildtype hspb11 expression pattern (Figure 4G and
I). To exclude that the lack of hspb11 expression pattern is caused
Figure 2. APM concentration dependent induction of hspb11,
pdlim3b and socs3a in zebrafish embryos. APM exposures for (A)
24 h (26–50 hpf) and (B) 2 h (48–50 hpf). Concentrations are given in
mM. Bars represent the relative gene expression as fold change of the
respective untreated control as mean 6 standard deviation of three
independent replicate exposures. Control = ctrl. * P,0.05.
doi:10.1371/journal.pone.0029063.g002
Figure 3. APM mediated hspb11 induction depends on nAChR
activity and increased intracellular calcium levels. (A) hspb11
expression analysis in ache and sop
fixe2/2 zebrafish mutant embryos at
48 hpf. (B) hspb11 expression in sop
fixe null mutants and siblings (+/? =
heterozygous and wildtype) after APM (6 mM) exposure (26–50 hpf). (C)
1 mM Thapsigargin (TG) and 2 mM caffeine (CAF) induce hspb11
expression in zebrafish embryos (exposure period 48–50 hpf). Bars
represent the relative gene expression as fold change of the respective
untreated control as mean 6 standard deviation of three independent
replicate exposures Control = ctrl. * P,0.05.
doi:10.1371/journal.pone.0029063.g003
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fixe2/2 embryos, we analyzed
the eng2a expression in sop
fixe2/2 embryos. It is known that
muscle pioneers highly express engrailed1 and engrailed2 genes [25].
In all embryos of a cross of heterozygous parents, we detected
muscle pioneer specific eng2a expression at 18 hpf (Figure S5C).
These altered hspb11 expression patterns led us to ask if the hspb11
expression is muscle-activity dependent and can be repressed by
blocking the muscle contraction with the anesthetic MS-222, a
voltage-gated Na+ channel blocker, in order to prevent action
potentials. Treatment with MS-222 [0.5 mM] for a 6 h (18 hpf to
24 hpf) resulted in a significant hspb11 repression (Figure 5A) and
the wildtype hspb11 expression pattern was lost (Figure 5B and C).
This suggests that the developmental hspb11 gene expression is
muscle activity dependent.
Hspb11 is Involved in Slow Muscle Myosin Organization
and/or Maintenance
To examine the developmental function of Hspb11, we
performed a morpholino-mediated knockdown of Hspb11.
Therefore we used two translation-blocking morpholinos,
MO(ATG)-hspb11 and MO(59UTR)-hspb11, and a mismatch
control morpholino (mmMO-hspb11) that harbors five mismatches
compared to the MO(ATG)-hspb11 were used. To avoid interfer-
ence with nonspecifically induced apoptosis a morpholino directed
against p53 was co-injected [26]. To prove that the injected hspb11
morpholinos are specific to hspb11 mRNA we performed
additional control experiments. First, we injected a gfp mRNAs
that contains either the morpholino binding site for MO(ATG)-
hspb11 or MO(59UTR)-hspb11 upstream of the GFP coding
sequence and we detected a bright GFP fluorescence (Figure
S6). Coinjection of gfp mRNA with either MO(ATG)-hspb11 or
MO(59UTR)-hspb11 strongly reduced the GFP fluorescence
(Figure S6). Further, coinjection with the designed mmMO-hspb11
and gfp mRNA did not reduce the GFP fluorescence (Figure S6).
Both MO(ATG)-hspb11 and MO(59UTR)-hspb11 morphants
showed a ventral body curvature. In MO(ATG)-hspb11 and
MO(59UTR)-hspb11 injected embryos, 82% (n=79, 2 replicates)
and 73% (n=114, 2 replicates) showed a morphant phenotype,
respectively. The MO(59UTR)-hspb11 phenotype was much
stronger and mmMO-hspb11 control injected embryos showed
no effects (Figure 6A–C). Additionally, we tried to rescue this
morphant phenotype by coinjection of a hspb11 mRNA that is not
targeted by MO(ATG)-hspb11 and MO(59UTR)-hspb11. Coinjec-
tion of the hspb11 mRNA with either MO(ATG)-hspb11 or
MO(59UTR)-hspb11 reduced the ventral body curvature pheno-
types to 53% (n=98, 2 replicates) and 51% (n=137, 2 replicates),
respectively.
In MO(ATG)-hspb11, MO(59UTR)-hspb11 and mmMO-hspb11
injected embryos, we detected a wildtype eng2a expression pattern
in muscle pioneers at 18 hpf (Figure S5D and E). Furthermore,
knockdown of Hspb11 did not lead to a decrease in birefringence
(Figure 6D–F). However, 80% (n=10) of hspb11 morphants
showed a disruption in slow muscle myosin distribution. Gaps
were formed between slow myofibers in knockdown embryos
(Figure 6G–I). There are no other impairments, such as extra long
intersomitic myofibers, detached myofibers or defective myosepta.
This indicates that the development of muscle pioneers is not
Figure 4. Developmental hspb11 expression pattern in wildtype, APM exposed, ache and sop
fixe mutant embryos. Expression pattern of
hspb11 at 18 hpf were detected in developing adaxial musculature (A–A0). During later developmental stages, at 24 hpf, hspb11 mRNA transcripts
were restricted to muscle pioneers (B and B9) and became only expressed in the notochord at 50 hpf (C). (A, B) lateral view, (A9) dorsal view and (A0
and B9) cross sections. Increased expression pattern in axial musculature was observed in APM exposed (D) and homozygous (2/2) ache mutant
embryos (E). Hspb11 expression in homozygous sop
fixe2/2 embryos (F and G) and heterozygous/wildtype (+/?) siblings (H and I).
doi:10.1371/journal.pone.0029063.g004
Figure 5. Blocking the skeletal muscle contraction with MS-222
inhibits developmental hspb11 expression. (A) qPCR hspb11
expression analysis. (B) Wildtype hspb11 expression pattern at 24 hpf.
(C) MS222 treatment results in the loss of hspb11 expression pattern at
24 hpf.
doi:10.1371/journal.pone.0029063.g005
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superficial muscle cells is affected in the hspb11 morphants, which
suggests that Hspb11 is involved in slow muscle myofibril
organization and/or maintenance.
Discussion
By a comparative toxicogenomic approach we demonstrated
that the AChE inhibitor APM induced specific responses on the
gene expression levels in zebrafish embryos. Other non-AChE
inhibiting compounds (DMB and DNP) did not affect the same
cluster of genes. Gene set enrichment analyses (GSEA) revealed
APM affected genes as enriched in a couple of gene sets involved
in neuronal/muscle structure and differentiation. The enrichment
of genes within these gene sets particularly after 48 h of exposure
might indicate subtle morphological changes caused by APM. This
is supported by the birefringence analysis which revealed
structural alterations in muscular tissue. It is known that the lack
of AChE activity in zebrafish results in an increase of muscular
activity and can cause a progressive myopathy [5,8]. We showed
that genes of the APM-specific cluster (hspb11, pdlim3b and socs3a)
were differently expressed in response to various AChE inhibitors.
Pdlim3b, also known as Alp-like, is a structural protein and a
member of the PDZ/LIM protein family which are characterized
by the presence of both, a PDZ and a LIM domain [27]. Their
functions are related to actin anchorage in muscles and non-
muscle cells. PDZ/LIM proteins are required for muscle
development and maintenance as has been shown for zebrafish
pdlim7 [28]. During zebrafish development pdlim3b (alp-like)i s
expressed in myotomes [27]. Hence, changes in pdlim3b expression
in response to AChE inhibitors might be related to early
disturbances of muscle structure and differentiation. The compar-
ison of the responses to different AChE inhibitors and 4-
nitrophenol indicated that socs3a was not induced specifically by
AChE inhibitors. Socs3a belongs to the suppressor of cytokine
signaling (Socs) protein family. It negatively regulates cytokine
signaling in order to prevent excessive cytokine signaling that may
disturb the normal homeostasis and cellular functions [29,30].
Hspb11 is a member of the small heat shock proteins (sHSPs)
family, which is a subclass of HSPs characterized by their low
molecular weight and presence of the conserved a-crystalline
domain. Many sHSPs act to prevent or reverse improper protein
associations in an ATP independent manner and they are
expressed in nearly all species [31,32]. In our microarray
experiments, hspb11 was the only significantly induced member
of sHSPs in zebrafish embryos exposed to APM. Commonly, the
chaperone function, i.e. the support of correct protein folding, is
considered as major physiological role of sHSPs and is regarded as
the reason for their induction by a variety of stress factors [33]. It
has been shown that HSPs are involved in several other processes,
such as actin regulation, intermediate filaments assembly,
apoptosis signaling or regulation of the cellular redox status
[34,35]. Furthermore, various diseases are known to be linked to
mutations of sHSPs including cancer, neurodegenerations, and
myopathies [36,37]. Up to now, thirteen sHSPs are identified in
zebrafish and their developmental and heat shock induced
expression patterns have been described. The expression of hspb11
is strongly induced after heat shock and transcripts are found
throughout the somites and the hearts [38]. Hspb11 orthologs seem
to exist in nearly all vertebrates except mammals.
ACh is a neurotransmitter which is released by excitation of
motoneurons at the neuromuscular junction. Binding of acetyl-
choline to nAChR depolarizes membranes of adjacent muscle cells
and induces an intracellular calcium increase. Calcium acts as a
messenger linking excitation events at the membrane with
downstream effects, like contraction, ATP production and
transcription [39,40]. Thus, the observed altered expressions of
hspb11 could be mediated via the ACh/nAChR/calcium pathway.
In this case, transcriptional up-regulation would primarily be
observed in skeletal muscle tissues. An inactivation of nAChR
would result in a loss of hspb11 expression and ache mutants should
exhibit elevated hspb11 levels as well. Furthermore, it would be
likely that compounds, which do not activate nAChR but increase
cytosolic calcium levels, induce the expression of hspb11. Indeed,
the experimental observations clearly support the anticipated role
of nAChR and calcium, i.e. the ache 2/2 mutant exhibited an
Figure 6. Knockdown of Hspb11 results in slow muscle myosin disorganization in skeletal muscles. (A, D and G) mmMO-hspb11 injected
embryos. (B, E and H) MO(ATG)-hspb11 morphants. (C, F and I) MO(UTR)-hspb11 morphants. (A–C) Phenotypic observations of morpholino injected
embryos at 48 hpf. (D–E) Muscle organization determined with birefringence at 72 hpf. (G–I) Slow muscle myosin distribution at 72 hpf shown by
immunofluorescence staining with antibody F59. Arrows indicate gaps in fiber distribution.
doi:10.1371/journal.pone.0029063.g006
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exposed to APM. In sop
fixe2/2 mutants, which do not express a
functional nAChR, the hspb11 developmental expression pattern
was completely lost and an induction of hspb11 with APM was not
possible. This data and the repressed transcription of hspb11 by
MS-222 provided evidences that developmental hspb11 expression
is muscle activity dependent.
Modulation of intracellular calcium levels with thapsigargin or
caffeine, which most likely affect the whole zebrafish embryo and
is not restricted to muscles, resulted in hspb11 induction. Calcium
dependent signal transduction cascades play important roles in the
control of skeletal muscle gene expression in mammals and
increased calcium levels result in, for instance, suppression of gene
expression of myogenin and nAChR [41]. Likewise, in ache 2/2
mutant zebrafish embryos the sub-cellular localization of nAChRs
is disturbed [5]. In our study, however, we did not detect down-
regulation of muscle-specific genes such as nAChR or myogenin.
It has been shown in zebrafish that acetylcholine and calcium
signaling are required for the organization of slow muscle
myofibrils [42]. Additionally, zebrafish mutants that exhibit
disturbed calcium regulation in muscle tissues, such as ache, sop
fixe
or acc, showed disarrayed muscle fibers [5,18,43]. In our study, we
showed that hspb11 expression is modulated in ache and sop
fixe
mutants. A continuous elevation of calcium levels and subse-
quently enhanced calcium-activated protease activity has been
shown to cause myofibre degeneration [20,44]. This suggests that
the correct regulation of cytosolic calcium transients is important
for hspb11 gene expression and myofibril organization and Hspb11
may compensate for calcium-induced protein degradation. We
demonstrate that down-regulation of Hspb11 has no effect on
muscle pioneer development, which is supported by the eng2a
expression. Furthermore, morpholino knockdown of Hspb11
alters the distribution of slow muscle myosin. Hence, Hspb11 is
important for myofibril organization and/or maintenance.
Hspb11 may play a critical role in folding and assembly of
various sarcomeric proteins during myofibrillogenesis and it
remains to identify Hspb11 client proteins.
The transcriptional regulation of hspb11 can be mediated via
specific transcription factors, e.g. Creb, Nfat, Nf-kB, which are
important components of intracellular signaling pathways and are
regulated by calcium [45,46]. By analyzing sequences 5 kb
upstream of the hspb11 transcriptional start site, several putative
binding sites of these transcription factors are present (27 for Creb,
12 for Nfat, and 5 for Nf-kB, respectively, data not shown).
However, the precise mechanism of the hspb11 transcriptional
regulation remains to be further investigated.
In summary, the combination of comparative toxicogenomics
and functional analysis has led to the identification of hspb11 as a
possible marker for interference with neuromuscular signaling
and/or calcium signaling. Further research need to address how
elevated calcium levels and hspb11 expression are linked.
Materials and Methods
Ethics Statement
All zebrafish husbandry and experimental procedures were
performed in accordance with the German animal protection
standards and were approved by the Government of Saxony,
Landesdirektion Leipzig, Germany (Aktenzeichen 75-9185.64).
Based on the Guidelines on the protection of experimental animals by the
Council of Europe, Directive 2010/63/EU, which allows zebrafish
embryos to be used up to the moment of independent feeding
(approximately 5 days after fertilization). Because embryos used
here were no more than 4 days old, no license is required by
Council of Europe (1986), Directive 2010/63/EU or the local
authority.
Fish maintenance
A wildtype zebrafish strain (WiK) was obtained from the Max
Planck Institute of Developmental Biology (Tu ¨bingen, Germany)
and cultured at 26uC according to standard procedures [47].
Mutant lines ache
sb55, sop
fixe and smu
b577 have been described
previously and were kept at the Institute of Toxicology and
Genetics, Karlsruhe [5,18,48].
Chemical exposure experiments
Embryos were exposed from 2–50 hpf, 26–50 hpf, 48–50 hpf
and/or 12 hpf (5-somite stage) to 72 hpf in 100 ml crystallization
dishes covered with watchmaker glasses with the chemicals. The
following chemicals were used: APM (azinphos-methyl, CAS#86-
50-0, purity 98,5%, Fluka), DMB (1,4-dimethoxybenzene,
CAS#150-78-7, purity 99%, Sigma-Aldrich), 2,4-DNP (2,4-
dinitrophenol, CAS#51-28-5, purity 99%, Fluka), GAL (galanta-
mine hydrobromide, CAS#1953-04-4, purity 98%, Sigma),
propoxur (CAS#114-26-1, purity 99,9%, Fluka), disulfoton
(CAS#298-04-4, purity 99%, Fluka), 4-nitrophenol (CAS#100-
02-7, Fluka), thapsigargin (CAS#67526-95-8, purity $98%,
Sigma), caffeine (CAS#58-08-2, purity $99%, Fluka) and MS-
222 (Ethyl 3-aminobenzoate methanesulfonate, CAS#886-86-2,
purity 98%, Sigma-Aldrich). Stock solutions of the chemicals were
prepared either in exposure medium (294.0 mg/L CaCl2*2H2O,
123.3 mg/L MgSO4*7H2O, 64.7 mg/L NaHCO3, 5.7 mg/L
KCl; according to ISO guideline 15088 or DMSO (thapsigargin)).
Exposure concentrations were prepared by dilution of stock
solutions. In case of thapsigargin DMSO concentration in
exposure and control media was adjusted to 0.01%. Exposure
concentrations of APM, DMB and DNP were analyzed by GC-
MS by the TZW (Technologie Zentrum Wasser, Karlsruhe,
Germany). After 48 h of exposure 90% (APM, 5.23 mmol/L), 75%
(DMB, 379 mmol/L) or 74% (DNP, 10.6 mmol/L), respectively, of
the nominal concentrations could be detected.
Microarray analysis
RNA was extracted from 50 embryos for each treatment
(controls and embryos exposed to the LC10, 4 independent
biological replicates each). We used the 4644 K Agilent D. rerio
oligo microarrays (Amadid #015064, Agilent, Bo ¨blingen, Ger-
many). The synthesis/labeling of cRNA with Cy3 (Agilent Low
RNA Input Linear Amplification Kit) and hybridizations with the
microarray slides were performed according to the manufacturer’s
instructions. Slides were scanned with an Agilent DNA Microarray
Scanner.
Fluorescent intensities of individual microarray spots were
extracted using the Agilent Feature Extraction software (Version
9.1). Log2-transformed fluorescent intensities were quantile
normalized and used to calculate the ratio for each treatment
versus the mean fluorescent value of the respective control.
Analysis of statistical significance with SAM [49], false discovery
rate adjusted to 0, p,0.03) and hierarchical clustering were
performed with these ratios and the TMEV software package
version 4.3 [www.tm4.org] [50]. The microarray data is MIAME
compliant, and raw and normalized data have been submitted to
the Gene Expression Omnibus (GEO) database [www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc= GSE27680].
For the identification of biological functions and pathways
associated with the changes in gene expression caused by the
APM treatment, Gene Set Enrichment Analyses (GSEA) [www.
broadinstitute.org/gsea/index.jsp] [51,52] was performed. Since
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based, contains mostly human and rodent gene sets, we used the
human ortholog gene names/annotations for this analysis.
Human orthologs of the whole microarray probe set were
assigned using Biomart [http://www.ensembl.org/biomart/index.
html]. GSEA was performed using the complete dataset whereas
5961 genes, i.e. those for which a human ortholog was identified,
could be associated with gene sets from the database. The gene sets
of the MSigDB (v3.0) databases C2 (Gene sets collected from
various sources such as online pathway databases, publications in
PubMed, and knowledge of domain experts) and C5 (Gene sets of
Gene Ontology terms) were used for the analysis.
AChE activity assay
Zebrafish embryos were exposed with different APM concen-
trations for 24 h (26–50 hpf). 30 embryos were used for AChE
activity assay and were performed as previously described [53].
Non-linear modeling was performed from the plot of AChE
activities with JMP 8.0 software (SAS, Cary, NC).
Quantitative real-time PCR analysis
Total RNA was extracted from 50 control, mutant or exposed
zebrafish embryos at 50 hpf. 2 mg of total RNA was reversely
transcribed with RevertAid
TM H Minus Reverse Transcriptase
(Fermentas) according to the manufacturer instructions. qPCR
was carried out using Step-One-Plus PCR System (Applied
Biosystems) and we used the SensiMix
TM
SYBR with ROX as
passive reference (Bioline). qPCR experiments were performed
with three independent biological replicates and each single run
was performed in three replicate samples. Statistical analysis of
qPCR experiments were performed with one-way ANOVA
followed by Dunnett’s post test using GraphPad Prism 5.0
software (GraphPad Software, San Diego California USA). Primer
sequences are given in Table S1. Relative expression levels were
determined by using the DDCt method [54].
Cloning, in situ hybridization, immunohistochemistry,
and microscopy
The open reading frame (ORF) of hspb11 was amplified with
ORF primers (Table S2), cloned into pCRII-blunt vector
(Invitrogen) and was verified by sequencing. This construct was
used for the synthesis of in situ hybridization probes. GFP
constructs were amplified with F1-MOATG-gfp/R1-GFP
primers for atg-gfp and F2-MOUTR-gfp/R1-GFP primers for
utr-gfp (Table S2) using pEGFP-N1 (Clonetech) vector as
template. Construct for the rescue experiment was generated
by using mmhspb11-F/hspb11-ORF_Rev primers (Table S2)
and hspb11-ORF-pCRII vector as template. Products were
cloned into pCRII blunt vector (Invitrogen) and subcloned into
pCS2P+. We performed whole-mount in situ hybridization
(WISH) and immunohistochemistry as described previously
[55,56]. We used the monoclonal antibody directed against
slow muscle myosin (F59). The F59 monoclonal antibody
developed by Frank E. Stockdale was obtained from the
Developmental Studies Hybridoma Bank developed under the
auspices of the NICHD and maintained by The University of
Iowa, Department of Biology, Iowa City, IA 52242. WISH was
performed with ,50 embryos per treatment if not stated
elsewhere. Birefringence was analyzed with a stereomicroscope
(MZ16F; Leica, Wetzlar, Germany) as described previously [5].
A Leica compound microscope (DM 5000B) and LCS software
(Leica, Wetzlar, Germany) were used to analyze antibody
staining.
Morpholino knockdown and mRNA injection
Morpholinos (Gene Tools, LLC, Philomath, OR) were
dissolved in water and injected at the following concentrations:
0,25 mM – 1 mM MO(ATG)-hspb11 (59- TCGGGCAAAG-
CATCTTCAGTGGATT- 39); 0,25 mM–1 mM mmMO-hspb11
(59-TCcGGgAAAGgATCTTCAcTGcATT-39) was a 5 base
mismatch control for MO(ATG)-hspb11; 0,25 mM–0,5 mM
MO(59UTR)-hspb11 (59- TTTGCTGTTGAGCTGTTTGGC-
TTCT- 39); 0,25 mM–1 mM MO-p53 (59-GACCTCCTCTC-
CACTAAACTACGAT-39). 59 capped mRNAs were transcribed
from linearized vectors using the mMESSAGE mMACHINE SP6
Kit (Applied Biosystems/Ambion, Austin, TX). Injection needles
were pulled from borosilicate glass capillary tubes with filament
(GC100F-10; Warner Instruments, LLC, Hamden, CT) using a
Narishige micropipette puller (Tokyo, Japan). Embryos were
injected with the Eppendorf FemtoJet (Hamburg, Germany)
through the chorion into the yolk compartment at the one-cell
stage.
Supporting Information
Figure S1 Acute toxicity of AMP, DMB and DNP in
zebrafish embryos. Dose response curves were determined by
recording mortality in 2–50 hpf exposed embryos. Non linear
regression modeling was performed with SigmaPlot version 11
(Systat Sofware Inc., San Jose, California) using the Hill 4
parameter equation (f=y0+a*x‘b/(c‘b+x‘b)).
(TIF)
Figure S2 AChE enzymatic activity in response to
various APM concentrations. AChE enzyme activities are
expressed as fold change of controls (based on specific activity). (n
= 3, exposures from 26–50 hpf).
(TIF)
Figure S3 Heat map of a hierarchical cluster analysis of
genes significantly differentially expressed in zebrafish
embryos. Embryos were exposed for 24 h (26–50 hpf) or 48 h
(2–50 hpf) to azinphos-methyl (APM), 1,4-dimethoxybenzene
(DMB) or 1,2-dinitrophenol (DNP). Genes with significantly
altered expression were identified using SAM (TM4 software
suite). Treatments were performed by two separate series of
experiments, one for the 24 h exposure and one for the 48 h
exposure. C24 and C48 are control samples that refer to these
separate experiments. Data represent the log2-ratio of each
treatment or control to the average of control levels (either C24
or C48). Numbers 1–4 indicate different independent biological
replicates. The cluster of genes, which are specifically regulated by
APM, is marked by orange lines.
(TIF)
Figure S4 qPCR analysis of hspb11, pdlim3b and socs3a
expression in zebrafish embryos. Embryos were exposed
from 26–50 hpf to different AChE inhibitors. (A) Propoxur, (B)
disulfoton, and (C) galantamine. (D) 4-nitrophenol served as
unspecific (non-acetylcholinesterase inhibiting) control. Concen-
trations are given in mM if not differently labeled. Bars represent
the relative gene expression as fold change of the respective
untreated control as mean 6 standard deviation of three replicate
exposures. Control = ctrl. * P,0.05.
(TIF)
Figure S5 Muscle pioneer specific expression analysis
of hspb11 and eng2a expression. (A) Transcripts of hspb11
mRNA are localized in muscle pioneers of wildtype or smu
heterozygous embryos (+/?). (B) smu2/2 embryos lack muscle
Muscle Activity Dependent Expression of hspb11
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sop
fixe2/2 mutants show wildtype eng2a expression in muscle
pioneers and at the midbrain-hindbrain boundary (mhb). (D and
E) Muscle pioneer development in MO(UTR)-hspb11 and
mmMO-hspb11 injected embryos was not effected, confirmed by
eng2a expression.
(TIF)
Figure S6 MO(ATG)-hspb11 and MO(59UTR)-hspb11
morpholinos specifically target their hspb11 binding
sites. Embryos injected with gfp mRNA that contains the MO
binding site expresses GFP. Co-injection of MO(ATG)-hspb11 or
MO(59UTR)-hspb11 with the gfp mRNA abolishes GFP expres-
sion, whereas with the mmMO-hspb11 morpholino does not
reduce GFP expression. atg-gfp mRNA contains MO(ATG)-hspb11
binding site. utr-gfp mRNA contains MO(UTR)-hspb11 binding
site.
(TIF)
Table S1 Gene sets exhibiting greatest overlap to
differentially expressed genes in APM treated zebrafish
embryos. The analysis was performed by the software GSEA
(gene set enrichment analysis) for all genes of which a human
ortholog could be identified. Gene expression patterns of APM-
treatments were compared to all other treatments (controls,
exposure to 1,4-dimethoxybenzene and 1,2-dinitrophenol). Only
gene sets with a p-value,0.01 are shown.
(XLS)
Table S2 List of primers used in this study.
(XLS)
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